loadpatents
name:-0.032548189163208
name:-0.016381978988647
name:-0.0061430931091309
MOSS; Stephen Frederick Patent Filings

MOSS; Stephen Frederick

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOSS; Stephen Frederick.The latest application filed is for "polymyxin derivatives and their use in combination therapy together with different antibiotics".

Company Profile
4.13.24
  • MOSS; Stephen Frederick - Ongar GB
  • Moss; Stephen Frederick - Ickleton GB
  • Moss; Stephen Frederick - Harlow GB
  • Moss; Stephen Frederick - Essex GB
  • Moss, Stephen Frederick - Harlow Essex GB
  • Moss; Stephen Frederick - Cambs GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymyxin Derivatives And Their Use In Combination Therapy Together With Different Antibiotics
App 20210221848 - BROWN; Pamela ;   et al.
2021-07-22
Compounds for use in antibacterial applications
Grant 10,683,307 - Cui , et al.
2020-06-16
Compounds For Use In Antibacterial Applications
App 20190270755 - CUI; Haifeng ;   et al.
2019-09-05
Compounds for use in antibacterial applications
Grant 10,364,254 - Cui , et al.
2019-07-30
Compounds For Us In Antibacterial Applications
App 20190031680 - CUI; Haifeng ;   et al.
2019-01-31
Compounds
App 20180030092 - Brown; Pamela ;   et al.
2018-02-01
Polymyxin Derivatives And Their Use In Combination Therapy Together With Different Antibiotics
App 20170073373 - Brown; Pamela ;   et al.
2017-03-16
Quinoline derivatives and their use as 5-HT.sub.6 ligands
Grant 8,236,947 - Ahmed , et al. August 7, 2
2012-08-07
Quinoline Derivatives And Their Use As 5-ht6 Ligands
App 20110237792 - AHMED; Mahmood ;   et al.
2011-09-29
Quinoline derivatives and their use as 5-HT6 ligands
Grant 7,977,337 - Ahmed , et al. July 12, 2
2011-07-12
Quinoline Derivatives And Their Use As 5-ht6 Ligands
App 20100305107 - AHMED; Mahmood ;   et al.
2010-12-02
Quinoline derivatives and their use as 5-HT.sub.6 ligands
Grant 7,799,774 - Ahmed , et al. September 21, 2
2010-09-21
Quinoline Derivatives And Their Use As 5-ht6 Ligands
App 20090298841 - Ahmed; Mahmood ;   et al.
2009-12-03
Quinoline derivatives and their use as 5-HT6 ligands
Grant 7,601,837 - Ahmed , et al. October 13, 2
2009-10-13
Heterocyclic urea derivatives for the treatment of pain
Grant 7,528,151 - Moss , et al. May 5, 2
2009-05-05
Quinoline Derivatives and Their Use as 5-HT6 Ligands
App 20090036682 - AHMED; Mahmood ;   et al.
2009-02-05
Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor
App 20090012056 - Ahmed; Mahmood ;   et al.
2009-01-08
Quinoline derivatives and their use as 5-ht6 ligands
Grant 7,452,888 - Ahmed , et al. November 18, 2
2008-11-18
8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
App 20080275040 - Johnson; Christopher Norbert ;   et al.
2008-11-06
Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders
Grant 7,439,243 - Johnson , et al. October 21, 2
2008-10-21
Novel Compounds
App 20070232657 - Ahmed; Mahmood ;   et al.
2007-10-04
Heterocyclic urea derivatives for the treatment of pain
App 20070117820 - Moss; Stephen Frederick ;   et al.
2007-05-24
Piperazinyl-quinoline derivatives useful for the treatment of cns disorders
App 20070027139 - Johnson; Christopher Norbert ;   et al.
2007-02-01
2-(pyrazol-3-yl)carbapenem derivatives
Grant 7,045,619 - Hunt , et al. May 16, 2
2006-05-16
Benzenesulfonamide derivatives as antipsychotic agents
App 20050222124 - Bromidge, Steven Mark ;   et al.
2005-10-06
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders
App 20050176759 - Ahmed, Mahmood ;   et al.
2005-08-11
Novel compounds
App 20050124626 - Johnson, Christopher Norbert ;   et al.
2005-06-09
Novel compounds
App 20050124628 - Ahmend, Mahood ;   et al.
2005-06-09
7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders
App 20050090485 - Bromidge, Steven Mark ;   et al.
2005-04-28
Isoquinoline derivatives useful in the treatment of CNS disorders
Grant 6,849,644 - Bromidge , et al. February 1, 2
2005-02-01
Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists
App 20040192671 - Bromidge, Steven Mark ;   et al.
2004-09-30
Isoquinoline derivatives useful in the treatment of cns disorders
App 20040053956 - Bromidge, Steven Mark ;   et al.
2004-03-18
N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfona- mide
App 20040034036 - Bromidge, Steven Mark ;   et al.
2004-02-19
2-(pyrazol-3-yl)carbapenem derivatives
App 20030166923 - Hunt, Eric ;   et al.
2003-09-04
Compounds
Grant 6,548,504 - Bromidge , et al. April 15, 2
2003-04-15
2-(pyrazol-3-yl)carbapenem derivatives
App 20020147333 - Hunt, Eric ;   et al.
2002-10-10
Compounds
Grant 6,316,450 - Bromidge , et al. November 13, 2
2001-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed